RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Masimo Stock

Masimo Revenue 2024

Masimo Revenue

2.13 B USD

Ticker

MASI

ISIN

US5747951003

WKN

578074

In 2024, Masimo's sales reached 2.13 B USD, a 3.85% difference from the 2.05 B USD sales recorded in the previous year.

The Masimo Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e2.934,60
2028e2.6338,10
2027e2.4940,25
2026e2.4141,60
2025e2.1845,95
2024e2.1347,18
20232.0549,00
20222.0452,01
20211.2465,23
20201.1464,97
20190.9467,09
20180.8666,98
20170.7966,06
20160.7167,09
20150.6365,07
20140.5966,62
20130.5565,57
20120.4966,16
20110.4466,99
20100.4170,45
20090.3571,27
20080.3170,86
20070.2671,28
20060.2272,54
20050.1160,43
20040.0757,64

Masimo Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Masimo, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Masimo from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Masimo’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Masimo. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Masimo’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Masimo’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Masimo’s growth potential.

Masimo Revenue, EBIT and net profit per share

DateMasimo RevenueMasimo EBITMasimo Net Income
2029e2.9 B undefined0 undefined0 undefined
2028e2.63 B undefined453.49 M undefined0 undefined
2027e2.49 B undefined417.79 M undefined0 undefined
2026e2.41 B undefined423.71 M undefined274.21 M undefined
2025e2.18 B undefined380.62 M undefined253.55 M undefined
2024e2.13 B undefined331.08 M undefined219.96 M undefined
20232.05 B undefined164.3 M undefined81.5 M undefined
20222.04 B undefined226.6 M undefined143.5 M undefined
20211.24 B undefined275.8 M undefined229.6 M undefined
20201.14 B undefined255.3 M undefined240.3 M undefined
2019937.8 M undefined221.2 M undefined196.2 M undefined
2018858.3 M undefined208.4 M undefined193.5 M undefined
2017790.2 M undefined183.8 M undefined124.8 M undefined
2016712.9 M undefined165.9 M undefined311.1 M undefined
2015630.1 M undefined100.7 M undefined83.3 M undefined
2014586.6 M undefined93.2 M undefined72.5 M undefined
2013547.2 M undefined87.7 M undefined58.4 M undefined
2012493.2 M undefined85.2 M undefined62.3 M undefined
2011439 M undefined101.2 M undefined63.7 M undefined
2010405.4 M undefined90.2 M undefined73.5 M undefined
2009349.1 M undefined82.5 M undefined53.2 M undefined
2008307.1 M undefined72.1 M undefined31.9 M undefined
2007256.3 M undefined68.4 M undefined23.1 M undefined
2006224.3 M undefined46.4 M undefined61.8 M undefined
2005107.9 M undefined13.8 M undefined5.5 M undefined
200469.4 M undefined3.8 M undefined-12.3 M undefined

Masimo stock margins

The Masimo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Masimo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Masimo.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Masimo's sales revenue. A higher gross margin percentage indicates that the Masimo retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Masimo's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Masimo's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Masimo's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Masimo. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Masimo's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Masimo Margin History

Masimo Gross marginMasimo Profit marginMasimo EBIT marginMasimo Profit margin
2029e49 %0 %0 %
2028e49 %17.22 %0 %
2027e49 %16.76 %0 %
2026e49 %17.57 %11.37 %
2025e49 %17.43 %11.61 %
2024e49 %15.57 %10.34 %
202349 %8.02 %3.98 %
202252.01 %11.13 %7.05 %
202165.23 %22.26 %18.53 %
202064.97 %22.32 %21.01 %
201967.09 %23.59 %20.92 %
201866.98 %24.28 %22.54 %
201766.06 %23.26 %15.79 %
201667.09 %23.27 %43.64 %
201565.07 %15.98 %13.22 %
201466.62 %15.89 %12.36 %
201365.57 %16.03 %10.67 %
201266.16 %17.27 %12.63 %
201166.99 %23.05 %14.51 %
201070.45 %22.25 %18.13 %
200971.27 %23.63 %15.24 %
200870.86 %23.48 %10.39 %
200771.28 %26.69 %9.01 %
200672.54 %20.69 %27.55 %
200560.43 %12.79 %5.1 %
200457.64 %5.48 %-17.72 %

Masimo Aktienanalyse

What does Masimo do?

Masimo Corporation is an American medical technology company based in Irvine, California. The company was founded in 1989 by Professor Joe Kiani, who is still the chairman and CEO of the company today. With innovative products and advanced technology, Masimo aims to optimize medical diagnostic and treatment procedures to improve patient care. The business model of Masimo Corp focuses on developing and marketing products and solutions for patient monitoring and treatment in hospitals, intensive care facilities, and outpatient clinics. The company relies on high levels of innovation and collaboration with physicians, scientists, and other experts. The goal is to improve existing medical procedures, explore new applications for the technology, and optimize patient care. Masimo Corp's products are divided into different divisions that focus on various aspects of medical care. One example is the "Patient Monitoring" division, which offers various monitoring systems for vital signs such as respiration, pulse, and oxygen saturation. This includes products like the Rad-67 pulse oximeter or the Root patient monitor, which continuously monitor patients during treatment to enhance safety and effectiveness. Another division is "Anesthesia and Sedation," which focuses on solutions for anesthesiologists and intensive care specialists. Masimo Corp offers products such as the SedLine brain monitor or the EMMA main gas monitor, which enable physicians to control anesthesia depth more precisely and reduce the risk of complications. In addition to patient monitoring systems, Masimo Corp also provides solutions for neonatal care. The "Neonatal Care" division includes products like the Masimo Radical-7 pulse oximeter for monitoring premature infants or the Pronto-7 pulse oximeter for fast and accurate monitoring of newborns in the delivery room. Furthermore, Masimo Corp has developed products for monitoring surgical patients. The "Surgical and Minimally Invasive Monitoring" division, for example, offers the MOC-9 monitoring system for precise monitoring of hemodynamics during surgery. A unique product of Masimo Corp is also the Masimo SET sensor, which provides more accurate and reliable measurement of blood oxygen saturation than traditional pulse oximeter sensors. The company has filed over 100 patents worldwide for this technology and has been recognized with numerous awards and accolades. In summary, Masimo Corp is an innovative company specializing in improving medical care through the development and marketing of products for patient monitoring and treatment. With its state-of-the-art technologies and collaboration with experts in medical research, Masimo Corp sets standards for patient safety and treatment effectiveness. Masimo ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Masimo's Sales Figures

The sales figures of Masimo originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Masimo’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Masimo's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Masimo’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Masimo stock

How much revenue did Masimo generate this year?

Masimo has achieved a revenue of 2.13 B USD this year.

How much was the turnover of the company Masimo compared to the previous year?

The revenue of Masimo has increased by 3.85% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Masimo?

The revenue of Masimo is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Masimo measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Masimo so important for investors?

The revenue of Masimo is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Masimo pay?

Over the past 12 months, Masimo paid a dividend of 1 USD . This corresponds to a dividend yield of about 0.58 %. For the coming 12 months, Masimo is expected to pay a dividend of 6.54 USD.

What is the dividend yield of Masimo?

The current dividend yield of Masimo is 0.58 %.

When does Masimo pay dividends?

Masimo pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Masimo?

Masimo paid dividends every year for the past 0 years.

What is the dividend of Masimo?

For the upcoming 12 months, dividends amounting to 6.54 USD are expected. This corresponds to a dividend yield of 3.79 %.

In which sector is Masimo located?

Masimo is assigned to the 'Health' sector.

Wann musste ich die Aktien von Masimo kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Masimo from 12/11/2012 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 11/23/2012.

When did Masimo pay the last dividend?

The last dividend was paid out on 12/11/2012.

What was the dividend of Masimo in the year 2023?

In the year 2023, Masimo distributed 0 USD as dividends.

In which currency does Masimo pay out the dividend?

The dividends of Masimo are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Masimo stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Masimo

Our stock analysis for Masimo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Masimo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.